Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for Weight Gain in Advanced Cancer Patients Receiving Chemotherapy
TCTR20240524004Phase 3Completed
- Sponsor
- Rajavithi Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in cancer, sponsored by Rajavithi Hospital. Started Jun 2024; status: completed.
02
Drugs
olanzapine
03
Conditions
cancer
Beyond the preview
Go deeper on TCTR20240524004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240524004.